Group 1 - The meeting of the Supervisory Board of Suzhou Mingzhi Technology Co., Ltd. was held on August 29, 2025, with all three supervisors participating in the voting, confirming the legality and validity of the meeting procedures [1][2] - The Supervisory Board approved the company's 2025 semi-annual report, stating that it accurately reflects the financial status and operational results of the company for the first half of 2025, and complies with relevant regulations [1][2] - The Supervisory Board also approved the special report on the storage and use of raised funds for the first half of 2025, confirming compliance with regulatory requirements and proper use of funds without harming shareholder interests [2][3] Group 2 - The Supervisory Board approved the proposal to conduct foreign exchange derivative trading, which is expected to effectively mitigate foreign exchange market risks and enhance the efficiency of foreign exchange fund usage [2][3]

Meeting Overview - The second meeting of the supervisory board of Nanjing Mailland Medical Technology Co., Ltd. was held on August 25, 2025, with all three supervisors present, confirming compliance with relevant laws and regulations [1] Financial Report Approval - The supervisory board approved the 2025 semi-annual report, affirming that the report's preparation and review processes adhered to legal requirements and accurately reflected the company's financial status and operational results [1] - The board ensured that there were no violations of confidentiality during the report's preparation [1] Fund Management Report - The board approved the special report on the storage and use of raised funds, confirming compliance with relevant regulations and that the actual use of funds matched previously disclosed information [2] Auditor Appointment - The board approved the reappointment of Zhongxinghua Accounting Firm, confirming its qualifications and ability to meet the company's auditing needs for the 2025 fiscal year [3] Related Party Transactions - The board approved an increase in the estimated amount for daily related party transactions for 2025, stating that it aligns with the company's operational needs and does not harm shareholder interests [4] Fund Replacement Proposal - The board approved a proposal to use self-raised funds for project payments, which will later be replaced with raised funds, enhancing operational efficiency without altering the intended use of raised funds [5] Governance Changes - The board approved the cancellation of the supervisory board and amendments to the company’s articles of association, aiming to improve governance in line with legal requirements [6]

Group 1 - The company held its 12th meeting of the 5th Supervisory Board on August 25, 2025, with all members ensuring the accuracy and completeness of the disclosed information [1] - The Supervisory Board approved the 2025 semi-annual report, confirming that it reflects the company's operational status and results accurately without any misleading statements [1] - The voting results for the semi-annual report were unanimous, with 3 votes in favor and no votes against or abstentions [1] Group 2 - The company plans to revise its articles of association and abolish the Supervisory Board's powers, transferring these to the Audit Committee of the Board of Directors [2] - The non-employee representative supervisors will no longer hold their positions following the approval of the proposal at the first extraordinary shareholders' meeting in 2025 [2] - The voting results for the proposal to amend the articles of association were also unanimous, with 3 votes in favor and no votes against or abstentions [2]

Core Points - The company held its 13th meeting of the 6th Supervisory Board on August 22, 2025, where all five supervisors attended and the meeting complied with legal and regulatory requirements [1][2][3] Group 1: Meeting Resolutions - The Supervisory Board approved the full and summary report for the first half of 2025, confirming that the report accurately reflects the company's situation without any false statements or omissions [1] - The Board approved the proposal to increase the estimated daily related party transaction limits for 2025, stating that the pricing of these transactions is objective and fair [2] - The Board agreed to reappoint Zhongshun Zhonghuan Accounting Firm as the auditing institution for 2025, pending approval from the shareholders' meeting [2] - The Board approved the proposal to abolish the Supervisory Board and the corresponding rules, transferring its responsibilities to the Audit Committee of the Board, which requires shareholder approval [3]

Group 1 - The fifth meeting of the supervisory board of Zhejiang Xiantong Rubber and Plastic Co., Ltd. was held on August 15, 2025, with all three supervisors present, confirming the legality and validity of the resolutions made [1][2]. - The supervisory board approved the company's 2025 semi-annual report and its summary, affirming that the report accurately reflects the company's financial status and operational results, in compliance with internal management regulations and relevant stock exchange rules [1][2]. - The voting results for the approval of the semi-annual report were unanimous, with 3 votes in favor, 0 against, and 0 abstentions [2]. Group 2 - The supervisory board confirmed that there were no violations of confidentiality by the personnel involved in the report [1]. - The company takes individual and joint responsibility for the authenticity, accuracy, and completeness of the information contained in the report [1]. - The full text and summary of the 2025 semi-annual report can be found on the Shanghai Stock Exchange website [2].

Group 1 - The Supervisory Board of Sichuan Huati Lighting Technology Co., Ltd. held its 10th meeting on August 22, 2025, with all three members present, complying with legal and regulatory requirements [1][2]. - The meeting approved the 2025 semi-annual report and summary, confirming that the report accurately reflects the company's operational and financial status without any false statements or omissions [2]. - The company recognized an asset impairment provision and credit impairment provision totaling 11,552,823.44 yuan, which reduced the consolidated profit by the same amount, representing 17.26% of the audited net profit attributable to shareholders for 2024 [2]. - The meeting also approved a special report on the storage and actual use of raised funds, confirming compliance with relevant regulations [2]. - A resolution was passed to abolish the Supervisory Board, transferring its powers to the Audit Committee of the Board of Directors, and to amend the company's articles of association accordingly [2][3].

Meeting Overview - The third meeting of the third supervisory board of Hangzhou Anjiasi Medical Technology Co., Ltd. was held on August 6, 2025, in a combination of on-site and remote formats, with all three supervisors present [1][2] - The meeting was chaired by the chairman of the supervisory board, Shi Baiming, and complied with the relevant provisions of the Company Law and the Articles of Association [1] Resolutions Passed - The supervisory board approved the proposal regarding the company's 2025 semi-annual report and its summary, affirming that the report complies with legal and regulatory requirements and accurately reflects the company's actual situation without any false statements or omissions [1][2] - The supervisory board also approved the special report on the storage and actual use of raised funds for the first half of 2025, confirming that the report objectively reflects the situation and that there were no violations in the use of raised funds during the reporting period [2][3]

Group 1 - The company held its fourth supervisory board meeting on July 11, 2025, with all three supervisors present, and the meeting was deemed legally valid [1] - The supervisory board approved the proposal to abolish the supervisory board, transferring its powers to the audit committee of the board of directors, pending approval from the shareholders' meeting [1][2] - The board will continue to fulfill its responsibilities until the shareholders' meeting votes on the proposal to cancel the supervisory board [1] Group 2 - The supervisory board approved the use of idle self-owned funds for cash management, allowing investments up to 500 million RMB in low-risk, high-liquidity financial products for a period of twelve months starting from August 25, 2025 [2][3] - The decision aims to enhance the efficiency of fund utilization and increase investment returns without harming the interests of the company and all shareholders, especially minority shareholders [2]

Group 1 - The supervisory board of Xinjiang Guannong Co., Ltd. held its 36th meeting, where all proposals were approved unanimously with no votes against or abstentions [1] - The meeting was conducted in accordance with the Company Law and the company's articles of association, with proper notification sent on March 22, 2025 [1][2] - The meeting took place on April 2, 2025, at the company's headquarters in Korla, Xinjiang [1] Group 2 - The supervisory board approved the 2024 annual work report, which will be submitted to the 2024 annual general meeting for review [2] - The board approved a proposal for asset disposal and impairment for 2024, totaling 243.92 million yuan, which will reduce the company's profit by the same amount [2] - The company will recognize credit impairment of 12.83 million yuan and asset impairment of 212.14 million yuan, along with goodwill impairment of 9.03 million yuan [2] Group 3 - The 2024 annual financial settlement report was approved, showing a net profit attributable to the parent company of 204.60 million yuan, a decrease of 71.58% compared to the previous year [2][3] - The profit distribution plan for 2024 and the mid-term dividend plan for 2025 were approved, emphasizing the company's commitment to long-term shareholder interests [3][4] Group 4 - The supervisory board approved the 2024 annual report and its summary, confirming that it accurately reflects the company's financial status and operational results [6] - The internal control evaluation and audit reports for 2024 were also approved, indicating compliance with relevant regulations [5] Group 5 - The board approved a proposal to apply for a total bank credit limit of 2 billion yuan from 15 financial institutions for the year 2025 [7] - The company will use up to 500 million yuan of idle funds for entrusted wealth management in 2025, focusing on low-risk financial products [8] Group 6 - The board approved the expected daily related transactions for 2025 and the investment in a seed industry innovation project not exceeding 27.31 million yuan [8] - A technical transformation investment plan for 2025 was approved, with a budget of up to 57.88 million yuan to enhance production efficiency and quality [9]